Since its inception in 1990, Corgenix and Corgenix UK is engaged in the development, manufacturing, and worldwide marketing of numerous products for the medical diagnostic industry. The mission and vision of Corgenix focuses on the following strategic areas: Continue development of innovative immunoassays for the clinical assessment of autoimmune and vascular diseases, promote strategic collaborations with other diagnostic companies that have the potential to benefit from Corgenix innovations including the licensing of proprietary Corgenix immunoassay technology, provide contract-manufacturing services for companies that may benefit from the expertise of Corgenix scientists, technology, and the state-of-the-art manufacturing facility, offer superior customer service by providing the most up to date information and innovations in this field and by consistently responding to customer concerns and needs, provide a positive working environment for employees while pursuing aggressive growth goals for the company.